Frank V. Booth

Health Technology

Consumer Services

Profile

Frank V.
Booth worked as a Principal at Eli Lilly & Co., as well as a Principal at Novo Nordisk, Inc. He also worked as the Chief Medical Officer at Sangart, Inc. Booth received both undergraduate and graduate degrees from the University of Oxford.

Former positions of Frank V. Booth

Companies	Position	End
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	Corporate Officer/Principal	-
ELI LILLY AND COMPANY	Corporate Officer/Principal	-
Sangart, Inc. Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA.	Chief Tech/Sci/R&D Officer	-

See the detail of Frank V. Booth's experience

Training of Frank V. Booth

University of Oxford

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies